Clinical Trials Browser

Phase 1/2 × Metastatic Castration Resistant Prostate Cancer × sabizabulin × Clear all

NCT03752099 2023-09-26

To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer

Phase 1/2 Terminated

Metastatic Castration Resistant Prostate Cancer